Canadian approval for Neuromedical Systems:
This article was originally published in Clinica
US company Neuromedical Systems has received clearance in Canada to market its Papnet cervical cancer testing system for primary screening. The system is already used in Europe and Asia as a primary screener and a US multicentre clinical trial has begun.
You may also be interested in...
P&G’s oral care business drove 35% of total category market growth in the firm’s fiscal 2020 and exemplifies its growth strategy for all segments – grow entire categories rather than take competitors’ market share, says CFO Jon Moeller.
The Pink Sheet explains the procedures underpinning the UK’s emergency use authorization of the Pfizer/BioNTech COVID-19 vaccine.
The US Food and Drug Administration posted two device-related closeout letters in November.